Vitacost Weighs Options After Losses; Shareholder Airs Complaints
This article was originally published in The Tan Sheet
Executive Summary
Activist shareholder Consac urges Vitacost.com to sell after operating losses four years in a row, despite close to $400 million in annual sales.
You may also be interested in...
Vitacost Seeks To Rebrand Site Beyond Supplement Sales
The e-commerce firm overhauls its logo and website, adding additional content and products to its inventory of more than 34,000 SKUs, bulking up in categories outside of traditional supplements, including conventional food, personal care and beauty products.
Vitacost.com Turns To Vitamin Shoppe Founder To Right Ship
Vitacost.com CEO Ira Kerker steps down and Jeffrey Horowitz takes the post after logistics challenges and a proxy fight shook up the company's board of directors
Rare Disease Roundtable: Dealing With Pricing Pressure
Part 2: High costs are built into the rare disease business model. Participants at a roundtable discussion led by Scrip at the J.P. Morgan Healthcare Conference talked about how much they are feeling the pressure on pricing.